Skip to main content

Share story

Robotics

NEURA Robotics and Qualcomm Enter Strategic Collaboration to Advance Physical AI and Cognitive Robotics

NEURA Robotics and Qualcomm Enter Strategic Collaboration to Advance Physical AI and Cognitive Robotics Image: Primary
Neura Robotics has entered a partnership with Qualcomm to develop the next generation of robots and physical AI. The German robotics startup and the semiconductor company announced the agreement on Monday. They plan to build the brain and nervous system of robots to advance humanoid and general purpose robots for domestic and industrial use. Neura will incorporate Qualcomm Dragonwing Robotics IQ10 processors as reference designs in its robots. The processors are intended for autonomous mobile robots and humanoids. Neura will also use its Neuraverse robotic simulation and training platform, released in June 2025, to test and fine tune robots running on the processors. David Reger, chief executive and founder of Neura Robotics, said in a press release that the collaboration marks a major step toward making physical AI real, open, scalable and trusted. He noted that the partnership combines the company's cognitive robotics platforms and Neuraverse ecosystem with Qualcomm Technologies leadership in edge AI and connectivity. The aim is to accelerate cognitive robots that operate safely alongside humans across industries and in everyday life.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.